Online pharmacy  
 
 Online pharmacy
 Allopatic pharmacy
 Ayurvedic pharmacy
 Regular cosmetics
 Ayurvedic cosmetics
 Alternative Medicine
 Hospital Equipment
 Anabolic Steroids
 Natural Antioxidants
 Anti-Aging Medicine
 Online pharmacy FAQ
 Medical Disclamer
 
  » Anti-Aging Medicine
Human Growth Hormone Product Line in alphabetical order:
A  E  G  H  I  J  N  O  S  
Ansomone
Generic name:   Recombinant Human Growth Hormone for Injection
Company:   Anhui Anke Biotechnology Co., Ltd.
Country:   China

Recombinant Human Growth Hormone for Injection
(Somatropin/HGH, rDNA Origin)
(EP / USP /CP /WHO Standard)

AnkeBio, leading and special in developing and manufacturing genetic pharmaceuticals, are the largest manufacturer of HGH (Recombinant Human Growth Hormone / Somatropin / Our Trade Name: ANSOMONE) conforming GMP Guideline approved by China State Drug Administration (which is top drug authority in China). Our products are rDNA origin and have been widely used in almost all the hospitals around China and exported to several countries.

We could supply HGH as Finished Form for Injection and Bulk Raw Drug in lyophilized powder for Personal Use and Trade.

QUALITY:
Our rHGH/ANSOMONE is qualified to EP, USP, CP, WHO Standard with high bio-activity and with 191 amino acids.

SIZES FOR INJECTION:
We have sizes of 2IU/vial, 4IU/vial, 15 IU/vial HGH Powder for Injection.
We could supply Sterile Water for Injection free of charge.

DELIVERY:
We will send out the goods by air express at sight of the funds to your indicated postal address. We will inform you the shipment date and track number, then you will track it on website till it arrives.

BRIEF INTRODUCTION:
ANSOMONE is a kind of sterile, lyophilized formulation of Recombinant Human Growth Hormone (HGH) with 191 amino acids, derived from engineering E.coli, and it is identical to the natural growth hormone in amino acid sequence and three-dimension structure. ANSOMONE is indicated for growth failure due to endogenous growth hormone deficiency (GHD) and Turner disease or Kidney failure. ANSOMONE can be used to heal up the surgery wound or burned wound and it has good effect to preservation for human aging. Our manufacturing plants of ANSOMONE are certified for GMP Standard by SFDA.

Chinese Phoneticize: Zhusheyong Chongzu Ren Shengzhangjisu
Composition in effect: Recombinant Human Growth Hormone

DESCRIPTION:
White loose lyophilized powder.

PHARMACOLOGY AND TOXICOLOGY:
Ansomone exerts the same actions of endogenous human growth hormone. It can stimulate proliferation and differentiation of epiphysis chondrocyte, stimulate growth of cartilage matrix cells, stimulate proliferation and differentiation of osteoblast; thus accelerate the liner growth rate and improve epiphysis width. AnsomoneĀ® can promote protein synthesis in whole body; reverse the negative nitrogen equilibrium caused by wound and surgery; correct the hypoproteinemia due to severe infection or hepatocirrhosis; stimulate synthesis of immune globin and proliferation of lymphadenoid, macrophage and lymphocyte, thus enhance the ability of infection resistance; stimulate proliferation of collagenocyte, fibroblast and macrophage in sites of burn and surgery, thus accelerate wound healing; promote synthesis of cardiocytes, thus improve cardiac contractility and reduce cardiac oxygen consumption; regulate lipometabolism, thus depress serum cholesterol and low density lipoprotein"s level; complement insufficiency or deficiency of growth hormone, regulate adult"s lipometabolism, osteometabolism, heart and kidney function.

PHARMACOKINETICS:
It is reported that the equal pharmacological effect could be achieved via subcutaneous (sc) or intramuscular (IM) administration. Even though sc may lead a higher concentration of GH in plasma, IM could also yield the same IGF-I level. The absorption of GH is the relatively slow, Cmax often occurs at 3-5 hours after injection. Clearance of GH is via liver and kidney, the half-life of clearance is about 2-3hours. Uncatabolized GH excreted in urea is almost immeasurable. All of the GH in circulation system exists as a complex form with GH binding proteins that make the half-life of GH prolonged.

INDICATIONS:
AnsomoneĀ® is indicated for the growth failure of children due to endogenous growth hormone deficiency (GHD), chronic renal insufficiency (CRI) and Turner"s syndrome. AnsomoneĀ® is indicated for severe burn.

USAGE:
When reconstitution, 1ml water for injection should be injected along the bottle wall, then swirl the vial with a gentle rotary motion until the contents are completely dissolved, do not shake violently.
The recommended dosage of AnsomoneĀ® for the treatment of children growth failure is 0.1~0.15IU/kg daily subcutaneous administration for 3 months to 3 years. Therapy regimen could be modified according to experienced doctor"s suggestion. The recommended dosage of AnsomoneĀ® for the treatment of severe burn is 0.2~0.4IU/kg daily subcutaneous administration for 2 weeks.

ADVERSE REACTIONS:
Growth hormone may cause transient hyperglycemia; it can be recovered as the administration proceeded or terminated.
Adverse reactions occurred in about 1% short stature children in clinical trial. Common adverse reactions include slight pain, tingle, turgescence around the injection site and peripheral edema, arthralgias. All of those adverse reactions often occurred at the beginning of treatment, and were temporal and tolerable. Long-term and high dosage administration of hGH may develop the antibodies in a few patients. However, the antibodies concentration could be rarely up to as high as 2mg/L that might affect the therapeutic efficiency.

CONTRAINDICATIONS:
1. AnsomoneĀ® should not be used in children whose epiphysis had been closed.
2. AnsomoneĀ® should not be used in cancer patients.
3. AnsomoneĀ® should not be used in patients in acute shock stage with severe infection.

WARNINGS AND PRECAUTIONS:
1. hGH therapy should be conducted on exactly diagnosed GHD patients under advice of experienced doctor.
2. For diabetes patients, dosage of anti-glucourea drugs should be adjusted during HGH therapy.
3. For patients whose GHD were caused by encephaloma or encephalic wound, the progress and the relapse possibility of potential diseases should be closely monitored.
4. For ACTH deficiency patients, dosage of ATCH should be adjusted because the growth improvement effect of HGH could be inhibited by simultaneous using of ACTH.
5. Thyroid gland function should be tested regularly because clinical hypothyroidism may occur to some patients during HGH therapy. For those hypothyroid, thyroid supplementation is necessary for ensuring the therapeutic effects of HGH.
6. Careful consideration should be taken if claudicating occurred during HGH therapy because the patients who suffered from endocrine system diseases (including GHD) have such a tendency that their epiphysis plates of femur are relatively easy to separate.
7. Growth hormone may lead to over insulin state, attention should be paid to if lower glucose intolerance appeared.
8. Do not take over-dose of HGH, one time over-dose HGH administration can lead to low blood sugar and succeeded with high blood sugar. Long-term over -dose HGH administration can lead to acromegaly.
9. Injection site should often variation in case lipoatrophy.

PREGNANT AND BABY-NURSING WOMEN USAGE:
It is not recommended for pregnant and nursing women to accept HGH therapy.

PEDIATRICS USAGE:
Response to HGH of children is similar to that of adults in pharmacology, toxicology and pharmacokinetics, HGH is safe for pediatric use.

OLD PATIENTS USAGE:
Response to HGH of old patients is similar to that of adults in pharmacology, toxicology and pharmacokinetics, HGH is safe for geriatric use.

INTERACTION WITH OTHER DRUGS:
Responses to HGH therapy might be inhibited by glucocorticoid, so that hydrocortisone dosage would be lower than 10~15mg/m2 of body surface during HGH therapy.
Simultaneous using of non-androgenic steroid during HGH therapy can accelerate growth rate.

OVERDOSAGE:
There is yet no report about over dosage of HGH; however, over dosage may cause some side effects, such as hypoglycemia at the beginning then succeeded with hyperglycemia. Long-term over dosage using of HGH can lead to acromegaly.

STORAGE: Keep at 2~8ƂĀ°C away from light. The reconstituted solution mixed with Sterile Water for Injection can be stored at 2~8? for 48 hours, do not be frozen.

LICENCE NUMBER:
GYZZS19990021(4IU/vial)
GYZZS19990022(2IU/vial) GOOD MANUFACTURING CERTIFICATE:

NB: As a professional and leading Manufacturer of HGH, In order to protect your benefits, we sincerely suggest:
1. We only guarantee our HGH/ANSOMONEĀ® with best quality.
2. Please kindly recognize and identify our trade brand HGH/ANSOMONEĀ® when you want to get our real products.Ā 

The minimum order is 100 IU.
We offer discount for over 500 IU per order.
Price (less shipping):   VIAL SIZE: 2, 4 IU/vial – $4.30
EXP:   2 years
Buy Now
Currency converter